<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-molecules-25-00942">
 <label>55.</label>
 <element-citation publication-type="web">
  <article-title>FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="http://investors.merck.com/news/press-release-details/2018/FDA-Accepts-New-Drug-Applications-for-Mercks-Doravirine-the-Companys-Investigational-Non-Nucleoside-Reverse-Transcriptase-Inhibitor-NNRTI-for-Treatment-of-HIV-1-Infection/default.aspx" xmlns:xlink="http://www.w3.org/1999/xlink">http://investors.merck.com/news/press-release-details/2018/FDA-Accepts-New-Drug-Applications-for-Mercks-Doravirine-the-Companys-Investigational-Non-Nucleoside-Reverse-Transcriptase-Inhibitor-NNRTI-for-Treatment-of-HIV-1-Infection/default.aspx</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2018-06-05">(accessed on 5 June 2018)</date-in-citation>
 </element-citation>
</ref>
